Statins in Diabetes Mellitus

Title:Statins in Diabetes Mellitus

Volume: 23 Issue: 46

Author(s): Charalambos Vlachopoulos*, Nikolaos Ioakeimidis, Konstantinos Aznaouridis, George Lazaros and Dimtris Tousoulis

Affiliation:

• Hypertension and Cardiometabolic Syndrome Unit, 1st Department of Cardiology, Medical School, National and Kapodistrian University of Athens, Hippokration Hospital, Athens,Greece

Keywords: Diabetes mellitus, statins, statin-induced diabetes mellitus, cardiovascular disease, clinical trials, dyslipidaemia.

Abstract: Statins are a group of lipid-lowering medications that have been proven to be efficient in the protection of patients with dyslipidaemia from cardiovascular disease. The beneficial role of statins in both primary and secondary prevention has been well documented in many large randomized clinical trials. This beneficial effect extends to patients with diabetes mellitus. Their safety profile is overall good with mainly mild side effects. However, data indicate that statins may promote new onset diabetes mellitus. We review the current evidence regarding the overall efficacy and safety profile of statins in patients with diabetes mellitus; further we put into a broader perspective the debated diabetogenic effect of these drugs.

Cite this article as:

Vlachopoulos Charalambos *, Ioakeimidis Nikolaos, Aznaouridis Konstantinos , Lazaros George and Tousoulis Dimtris , Statins in Diabetes Mellitus, Current Pharmaceutical Design 2017; 23 (46) . https://dx.doi.org/10.2174/1381612823666170816113915